Efficacy of Dapagliflozin in Patients with Type 2 Diabetes Mellitus and Baseline HbA1c=9.0%

被引:0
|
作者
Katz, Arie
Yeh, Helen
Sugg, Jennifer E.
Parikh, Shamik J.
List, James F.
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1094-P
引用
收藏
页码:A284 / A285
页数:2
相关论文
共 50 条
  • [1] THE EFFECT OF DAPAGLIFLOZIN ON HEDIS PERFORMANCE MEASURES OF HBA1C IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Bell, K.
    Hardy, E.
    De Bruin, T.
    Wei, L.
    Martin, P.
    Ptaszynska, A.
    VALUE IN HEALTH, 2012, 15 (04) : A171 - A172
  • [2] Efficacy and safety of canagliflozin by baseline HbA1c and known duration of type 2 diabetes mellitus
    Wilding, John P. H.
    Blonde, Lawrence
    Leiter, Lawrence A.
    Cerdas, Sonia
    Tong, Cindy
    Yee, Jacqueline
    Meininger, Gary
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (03) : 438 - 444
  • [3] Glycaemic efficacy of canaglilozin by baseline HbA1c and known duration of type 2 diabetes mellitus
    Cerdas, S.
    Leiter, L. A.
    Blonde, L.
    Wilding, J.
    Tong, C.
    Yee, J.
    Meininger, G.
    DIABETOLOGIA, 2014, 57 : S344 - S344
  • [4] THE IMPACT OF BASELINE HBA1C AND HBA1C TRAJECTORIES ON TIME TO THERAPY ESCALATION IN TYPE 2 DIABETES MELLITUS
    McEwan, P.
    Foos, V
    Larnotte, M.
    VALUE IN HEALTH, 2015, 18 (07) : A698 - A698
  • [5] Efficacy of orlistat in patients with type 2 diabetes with baseline HbA1c, levels ≥8%
    Davidson, JA
    Barnett, A
    DIABETES, 2002, 51 : A95 - A95
  • [6] Seasonal variation in HbA1c in patients with Type 2 diabetes mellitus
    Carney, TA
    Guy, SP
    Helliwell, CD
    DIABETIC MEDICINE, 2000, 17 (07) : 554 - 555
  • [7] Therapeutic effect and rebound evaluation of dapagliflozin on glycated hemoglobin (HbA1c) in type 1 diabetes mellitus patients
    Wang, Dong-Dong
    Zhang, Cun
    Hu, Ke
    He, Su-Mei
    Zhu, Ping
    Chen, Xiao
    FRONTIERS IN PHARMACOLOGY, 2023, 13
  • [8] Efficacy Increases With Increasing Baseline HbA1c Category With Dapagliflozin Therapy
    Hardy, Elise
    Salsali, Afshin
    Hruba, Veronika
    Mansfield, Traci
    Rohwedder, Katja
    Wessman, Catrin
    Sugg, Jennifer
    Wei, Li
    Ptaszyn-Ska, Agata
    Parikh, Shamik
    DIABETES, 2012, 61 : A23 - A23
  • [9] Relationship of baseline HbA1c and HbA1c reduction following insulin therapy in Type 2 diabetes
    Giugliano, D.
    Esposito, K.
    DIABETIC MEDICINE, 2011, 28 (02) : 247 - 247
  • [10] HbA1c as a Screening tool for Ketosis in Patients with Type 2 Diabetes Mellitus
    Zhu, Bing
    Bu, Le
    Zhang, Manna
    Gusdon, Aaron M.
    Zheng, Liang
    Rampersad, Sharvan
    Li, Jue
    Qu, Shen
    SCIENTIFIC REPORTS, 2016, 6